Skip to main content

Peer Review reports

From: Antimalarial activity of the anticancer and proteasome inhibitor bortezomib and its analog ZL3B

Original Submission
10 Jul 2007 Submitted Original manuscript
Author responded Author comments
Resubmission - Version 2
Submitted Manuscript version 2
Author responded Author comments
Resubmission - Version 3
Submitted Manuscript version 3
Author responded Author comments
Resubmission - Version 4
Submitted Manuscript version 4
Resubmission - Version 5
Submitted Manuscript version 5
Author responded Author comments
Reviewed Reviewer Report
Reviewed Reviewer Report
Resubmission - Version 6
Submitted Manuscript version 6
Author responded Author comments
Resubmission - Version 7
Submitted Manuscript version 7
Author responded Author comments
Resubmission - Version 8
Submitted Manuscript version 8
Publishing
23 Oct 2007 Editorially accepted
23 Oct 2007 Article published 10.1186/1472-6904-7-13

You can find further information about peer review here.

Back to article page